Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass

ClinicalTrials.gov ID: NCT00032630

Public ClinicalTrials.gov record NCT00032630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 9, 2026, 6:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CSP #517 - Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Ischemic heart disease is one of the most frequent diagnoses in the VA system. Moreover, 5,819 coronary artery bypass graft (CABG-only) procedures were performed in the VA in Fiscal Year (FY) 1999. Throughout VA and non-VA cardiac surgery programs nationwide, myocardial revascularization is now being performed using two surgical techniques. One technique is performed with cardiopulmonary bypass (CPB) usually with cardioplegic arrest ("on-pump") and the other without CPB on a beating heart ("off-pump"). The overall purpose of this proposed randomized, controlled, clinical trial is to rigorously evaluate the impact of using an on-pump versus off-pump surgical technique for coronary artery bypass graft (CABG-only) procedures (performed with a traditional median sternotomy incision) upon patient clinical outcomes and resource utilization.

Study identification

NCT ID
NCT00032630
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
2,203 participants

Conditions and interventions

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2002
Primary completion
Mar 31, 2008
Completion
Mar 31, 2008
Last update posted
May 4, 2014

2002 – 2008

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
VA Palo Alto Health Care System Palo Alto California 94304-1290
VA Medical Center, San Francisco San Francisco California 94121
VA Greater Los Angeles HCS, Sepulveda Sepulveda California 91343
VA Eastern Colorado Health Care System, Denver Denver Colorado 80220
VA Medical Center, DC Washington D.C. District of Columbia 20422
North Florida/South Georgia Veterans Health System Gainesville Florida 32608
VA Medical Center, Miami Miami Florida 33125
James A. Haley Veterans Hospital, Tampa Tampa Florida 33612
New Mexico VA Health Care System, Albuquerque Albuquerque New Mexico 87108-5153
VA Medical Center, Asheville Asheville North Carolina 28805
VA Medical Center, Durham Durham North Carolina 27705
VA Medical Center, Cleveland Cleveland Ohio 44106
VA Medical Center, Portland Portland Oregon 97201
VA Pittsburgh Health Care System Pittsburgh Pennsylvania 15240
VA North Texas Health Care System, Dallas Dallas Texas 75216
VA South Texas Health Care System, San Antonio San Antonio Texas 78229
Zablocki VA Medical Center, Milwaukee Milwaukee Wisconsin 53295-1000

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00032630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2014 · Synced Sep 9, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00032630 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →